Concord Medical Services Holdings Limited
CCM · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,717 | $11,884 | $16,469 | $6,119 |
| - Cash | $216,224 | $58,139 | $158,283 | $157,386 |
| + Debt | $3,930,731 | $3,295,701 | $3,239,879 | $2,732,657 |
| Enterprise Value | $3,720,224 | $3,249,446 | $3,098,065 | $2,581,390 |
| Revenue | $383,956 | $537,402 | $472,085 | $485,633 |
| % Growth | -28.6% | 13.8% | -2.8% | – |
| Gross Profit | -$79,162 | -$76,608 | -$152,409 | -$56,897 |
| % Margin | -20.6% | -14.3% | -32.3% | -11.7% |
| EBITDA | -$345,624 | -$344,156 | -$401,861 | -$363,859 |
| % Margin | -90% | -64% | -85.1% | -74.9% |
| Net Income | -$308,243 | -$297,658 | -$489,661 | -$271,427 |
| % Margin | -80.3% | -55.4% | -103.7% | -55.9% |
| EPS Diluted | -2,116.8 | -2,044.2 | -3,362.7 | -5,635.5 |
| % Growth | -3.6% | 39.2% | 40.3% | – |
| Operating Cash Flow | -$397,749 | -$276,471 | -$216,694 | -$359,313 |
| Capital Expenditures | -$410,834 | -$115,702 | -$383,773 | -$760,581 |
| Free Cash Flow | -$808,583 | -$392,173 | -$600,467 | -$1,119,894 |